Target intelligence / Profile preview

Apoptosis pathway in fibroblasts (None)

Target
None
Molecular classification
Other
01

Overview

The apoptosis pathway in fibroblasts describes the regulated sequence of molecular events leading to programmed cell death in fibroblast cells. This process involves both the intrinsic (mitochondrial) pathway, regulated primarily by Bcl-2 family proteins and mitochondrial outer membrane permeabilization, and the extrinsic pathway, which is triggered by activation of specific cell-surface death receptors such as Fas or TNF-R1. Key downstream effectors are proteases called caspases, which orchestrate the execution phase of apoptosis leading to DNA fragmentation, membrane changes, and cell clearance. Proper regulation of fibroblast apoptosis is essential for tissue homeostasis, wound healing, and the prevention of pathological states such as cancer and fibrosis. Therapeutic intervention typically targets individual pathway components—such as Bcl-2 family proteins, caspases, or death receptors—rather than the entire pathway itself[2][3][4][6].

Other names
Apoptosis signaling pathwayprogrammed cell death pathwaycell death pathway in fibroblasts
02

Mechanism of action

Inhibition of anti-apoptotic Bcl-2 proteins, promoting activation of the intrinsic pathway; Activation or blockade of death receptors like Fas or TNF-R1, modulating the extrinsic pathway; Direct inhibition of caspase activity, preventing apoptotic execution

03

Biological functions

ApoptosisCell deathTissue homeostasisResponse to cellular stressRegulation of development and disease
04

Disease associations

CancerFibrosisInflammationTissue repair and remodelingOther (role in degenerative diseases if fibroblast death is dysregulated)
05

Safety considerations

Excessive apoptosis induction can lead to tissue damage, impaired healing, and inflammationInhibition of apoptosis may promote cancer or fibrosisSystemic drugs targeting pathway components may have off-target effects due to ubiquitous expression
06

Interacting drugs

BH3 mimetics

2 more in the full profile.

07

Biomarkers

Bax/Bcl-2 ratioActivated caspasesCleaved PARPDeath receptor expression

Beyond the preview

Go deeper on Apoptosis pathway in fibroblasts (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis pathway in fibroblasts (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call